In vitro susceptibility of dermatophytes to oral antifungal drugs and amphotericin B in Uttar Pradesh, India

被引:10
作者
Singh, Satyendra Kumar [1 ]
Patwa, Dheeraj Kumar [1 ]
Tilak, Ragini [2 ]
Das, Arghya [2 ]
Singh, Tej Bali [3 ]
机构
[1] Banaras Hindu Univ, Inst Med Sci, Dept Dermatol & Venereol, Varanasi, Uttar Pradesh, India
[2] Banaras Hindu Univ, Inst Med Sci, Dept Microbiol, Varanasi, Uttar Pradesh, India
[3] Banaras Hindu Univ, Inst Med Sci, Dept Community Med, Div Biostat, Varanasi, Uttar Pradesh, India
关键词
Amphotericin-B; antifungal; dermatophytes; in vitro; resistance; voriconazole; TRICHOPHYTON-RUBRUM; RESISTANCE; ITRACONAZOLE; TERBINAFINE; AGENTS;
D O I
10.4103/ijdvl.IJDVL_319_18
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Dermatophytosis is a major public health problem in our country. Although resistance to conventional oral and topical antifungal agents is being increasingly encountered, the sensitivity pattern of dermatophytes has not been systematically analysed. Aims: We aimed to determine the sensitivity pattern of dermatophyte isolates to amphotericin B and six oral antifungal drugs. Materials and Methods: Patients with dermatophytosis attending the outpatient department of dermatology were enrolled in the study. Samples were collected for mycological examination and in vitro antifungal sensitivity testing was done by broth microdilution as per the Clinical and Laboratory Standard Institute M38-A standards. Results: A total of 804 patients were enrolled. Specimens from 185 patients (23%) were both KOH and culture positive, and 44 of these isolates (41 Trichophyton mentagrophytes and 3 Trichophyton rubrum) were subjected to sensitivity testing. Minimum inhibitory concentrations (MIC) of itraconazole, ketoconazole, voriconazole and amphotericin B were comparable. The median MIC to fluconazole was higher than the other tested drugs. Dermatophytes were most susceptible to ketoconazole and voriconazole, followed by itraconazole, amphotericin B, fluconazole and griseofulvin. A high incidence of resistance was found to terbinafine and the difference was statistically significant in comparison to fluconazole, itraconazole, voriconazole, ketoconazole (P = 0.001) and griseofulvin (P = 0.003). The strains were more sensitive to amphotericin B as compared to griseofulvin (P = 0.02) and terbinafine (P < 0.001). Limitations: This was a hospital-based study and may not reflect the true pattern in the community. Only a few of the isolates were selected for study. The clinical response of patients, whose isolates were studied for in vitro sensitivity of the antifungals, was not studied. Conclusions: The sensitivity pattern of dermatophytes to various antifungals including amphotericin B, ketoconazole, voriconazole and itraconazole were determined. The studied isolates were least susceptible to terbinafine.
引用
收藏
页码:388 / 392
页数:5
相关论文
共 50 条
  • [11] Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method
    Rojas, Florencia D.
    Sosa, Maria de los A.
    Fernandez, Mariana S.
    Cattana, Maria E.
    Cordoba, Susana B.
    Giusiano, Gustavo E.
    MEDICAL MYCOLOGY, 2014, 52 (06) : 641 - 646
  • [12] In vitro susceptibility of Aspergillus and Fusarium associated with equine keratitis to new antifungal drugs
    Roberts, Darby
    Cotter, Henry Van T.
    Cubeta, Marc
    Gilger, Brian C.
    VETERINARY OPHTHALMOLOGY, 2020, 23 (05) : 918 - 922
  • [13] Tailoring amphotericin B as an ionic liquid: an upfront strategy to potentiate the biological activity of antifungal drugs
    Hartmann, Diego O.
    Shimizu, Karina
    Rothkegel, Maika
    Petkovic, Marija
    Ferraz, Ricardo
    Petrovski, Zeljko
    Branco, Luis C.
    Lopes, Jose N. Canongia
    Pereira, Cristina Silva
    RSC ADVANCES, 2021, 11 (24) : 14441 - 14452
  • [14] In vitro susceptibility of chromoblastomycosis agents to antifungal drugs: A systematic review
    da Silva Hellwig, Alessandra Helena
    Heidrich, Daiane
    Zanette, Regis Adriel
    Scroferneker, Maria Lucia
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2019, 16 : 108 - 114
  • [15] Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole
    Carrillo-Muñoz, AJ
    Quindós, G
    Tur, C
    Ruesga, M
    Alonso, R
    del Valle, O
    Rodriguez, V
    Arévalo, MP
    Salgado, J
    Martin-Mazuelos, E
    Bornay-Llinares, FJ
    del Palacio, A
    Cuétara, M
    Gasser, I
    Hernández-Molina, JM
    Pemán, J
    CHEMOTHERAPY, 2000, 46 (04) : 235 - 244
  • [16] Design of amphotericin B oral formulation for antifungal therapy
    Liu, Min
    Chen, Meiwan
    Yang, Zhiwen
    DRUG DELIVERY, 2017, 24 (01) : 1 - 9
  • [17] A critical role of farnesol in the modulation of Amphotericin B and Aureobasidin A antifungal drug susceptibility
    Mahendrarajan, Venkatramanan
    Bari, Vinay Kumar
    MYCOLOGY-AN INTERNATIONAL JOURNAL ON FUNGAL BIOLOGY, 2022, 13 (04) : 305 - 317
  • [18] Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran
    Ansari, Saham
    Hedayati, Mohammad T.
    Zomorodian, Kamiar
    Pakshir, Keyvan
    Badali, Hamid
    Rafiei, Abdollah
    Ravandeh, Mostafa
    Seyedmousavi, Seyedmojtaba
    MYCOPATHOLOGIA, 2016, 181 (1-2) : 89 - 95
  • [19] In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity
    Gupta, AK
    Kohli, Y
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (02) : 296 - 305
  • [20] In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex
    Vaezi, Afsane
    Fakhim, Hamed
    Arastehfar, Amir
    Shokohi, Tahereh
    Hedayati, Mohammad T.
    Khodavaisy, Sadegh
    Rezaei-Matehkolaei, Ali
    Badiee, Parisa
    Hagen, Ferry
    Lass-Floerl, Cornelia
    Dannaoui, Eric
    Meis, Jacques F.
    Badali, Hamid
    MYCOSES, 2018, 61 (02) : 134 - 142